Author

B V Manjushree

Observed names: B. V. Manjushree, B.V. Manjushree, Manjushree B V, Manjushree B.V., Manjushree BV, Manjushree B V

ORCID: 0009-0000-1709-8989

Observed ORCID: 0009-0000-1709-8989

OpenAlex ID: A5098966127

Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies

2024 · Aayishamma I, Gurubasavaraja Swamy Purawarga Matada, et al. · European Journal of Medicinal Chemistry · 40

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship

2024 · Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, et al. · European Journal of Medicinal Chemistry · 33

Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight

2024 · Md. Ashadul Sk, Hemalatha K., et al. · Bioorganic Chemistry · 24

Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationship

2024 · Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, et al. · Journal of Molecular Structure · 24

Exploring Thiazolidine-2,4‑dione derivatives as privileged scaffolds for targeted anticancer agents: Biological activity and structure-activity relationship (SAR) insights

2024 · Viji M P, Gurubasavaraja Swamy Purawarga Matada, et al. · Journal of Molecular Structure · 8

Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)

2024 · B. V. Manjushree, Gurubasavaraja Swamy Purawarga Matada, et al. · ChemistrySelect · 7

Multistage Computational Evaluation of Bedaquiline Pyridyl Derivatives: Unveiling Anti‐Tubercular Potential Through QSAR, Molecular Docking, Molecular Dynamics, ADMET, and DFT Analysis

2026 · Anguraj Moulishankar, Gurubasavaraja Swamy Purawarga Matada, et al. · ChemistrySelect · 2

Fused tricyclic aromatic and heteroaromatic scaffolds as anticancer agents: Recent advances in medicinal chemistry, structure–activity relationships, and therapeutic potential

2026 · Manjushree B V, Gurubasavaraja Swamy Purawarga Matada, et al. · Journal of Molecular Structure

Rational Design, Synthesis, Biological Evaluation, and In Silico Study of N ‐Cinnamamide/Benzamide‐(4‐(Substituted Phenyl)‐6‐(4‐Cyclohexylphenyl)pyrimidin‐2‐yl) Derivatives as EGFR Inhibitors Targeting EGFR WT , EGFR T790M , and EGFR L858R / T790M / C797S in NSCLC

2026 · Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, et al. · Chemical Biology & Drug Design

Recent Advances in Microwave and Ultrasound Assisted Synthesis of Quinoline Derivatives as Anticancer Agents

2026 · Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, et al. · Chemistry & Biodiversity

Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure–activity relationship insights

2026 · Manjushree BV, Gurubasavaraja Swamy Purawarga Matada, et al. · Molecular Diversity

Works count: 11

Citation count: 138

H-index: 6

I10-index: 4